 |
Case Report
Clinical investigation of segmental zoster paresis: A case of rare motor complications of herpes zoster
1 MD, PhD, Professor, Department of Health, Faculty of Health Sciences, Tsukuba University of Technology, Tsukuba, Ibaraki, Japan
2 MD, PhD, Lecturer, Department of Internal Medicine, Ibaraki Western Medical Center, Ibaraki, Japan
3 MD, PhD, Professor, Department of Neurology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
4 MD, PhD, Professor, Department of Radiological Technology, Tsukuba International University, Ibaraki, Japan
Address correspondence to:
Nobuko Shiraiwa
4-12-7 Kasuga, Tsukuba, Ibaraki 305-8521,
Japan
Message to Corresponding Author
Article ID: 100075Z09NS2023
Access full text article on other devices
Access PDF of article on other devices
How to cite this article
Shiraiwa N, Terada M, Tamaoka A, Ohkoshi N. Clinical investigation of segmental zoster paresis: A case of rare motor complications of herpes zoster. J Case Rep Images Med 2023;9(2):1–4.ABSTRACT
Introduction: Motor involvement is a rare complication of herpes zoster (HZ) infection, which is referred to as segmental zoster paresis (SZP).
Case Report: We evaluated the clinical course of a rare case of motor complications of HZ. A 77-year-old man showed limb paresis, considered as SZP of the limb, of which one also had hemidiaphragmatic paralysis. The time between onset and start of antiviral drug administration was 29 days. An almost complete recovery from motor complications was achieved nine months after onset.
Conclusion: Segmental zoster paresis was found in an old patient aged ≥75 years. In addition to age, it was suggested that a delay in antiviral drug initiation may have caused SZP. However, further large prospective cohort studies are required. The patient has recovered from motor paralysis slowly over half a year, which is consistent with the prognosis of conventional SZP.
Keywords: Hemidiaphragmatic paralysis, Herpes zoster, Prognosis, Segmental zoster paresis
SUPPORTING INFORMATION
Acknowledgments
We would like to thank Dr. Kusunoki S in the Department of Neurology, Faculty of Medicine, Kindai University, for kindly providing the measurement of anti-ganglioside antibodies. We would also like to thank Editage (www.editage.jp) for English language editing.
Author ContributionsNobuko Shiraiwa - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Makoto Terada - Acquisition of data, Analysis of data, Interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Akira Tamaoka - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Norio Ohkoshi - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Guaranter of SubmissionThe corresponding author is the guarantor of submission.
Source of SupportNone
Consent StatementWritten informed consent was obtained from the patient for publication of this article.
Data AvailabilityAll relevant data are within the paper and its Supporting Information files.
Conflict of InterestAuthors declare no conflict of interest
Copyright© 2023 Nobuko Shiraiwa et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.
